Geneva, September 1st, 2022 - After almost 10 years driven by vision, passion and dedication under the leadership of Madiha Derouazi, the AMAL Therapeutics’ team has just welcomed a new CEO: Laetitia Devy Dimanche, who has taken over the role on September 1st.


Laetitia will continue to guide the Geneva site towards more successful years ahead, with the warm support of her team!

Share this entry

You are now leaving our website

Using this link will let you leave a website of Amal Therapeutics or to a different domain under the control of Amal Therapeutics. In the event that the linked site is not under the control of Amal Therapeutics but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, Amal Therapeutics shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites.

This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Amal Therapeutics of the site.

Target URL: